What cycle length and dose do sources give for turinabol?

Doses and schedules in the sources
TrialDose and schedulePeopleLength or timing
Vogel, 1984 treatment series15 or 10 mg a day by mouthTwenty patients with insufficient fibrinolysisFibrinolytic capacity began to increase four weeks after the start and reached a maximum in the 3rd and 4th months
Schumann, 1991 pharmacokinetic study2Single 10 mg dose by mouth; a single dose was also given intravenouslyMale volunteers (the report gives no number)Peak plasma level at about 3 h
Loke, 2021 controlled administration3Single 5 mg dose by mouthFive healthy menUrine collected for 60 days
Liedloff, 1989 controlled studies4Dehydrochlormethyl testosterone among various medicines; the report gives no dose437 patients with hip alloarthroplasty1980 to 1985; the report gives no arm sizes

The searches found no label dose or cycle length for turinabol; among the studies found, a 1984 series by Vogel and colleagues in twenty patients with insufficient fibrinolysis gave 5 or 10 mg a day by mouth, and their fibrinolytic capacity reached a maximum in the 3rd and 4th months of treatment.1

Doses and schedules in the sources

The table is set at the top of the page

Searches of DailyMed and the web returned no label, approval record or dose for turinabol, and no tablet strength for Oral-Turinabol. The PubMed searches found no cycle length or stepping; the 1984 Vogel series gives months of treatment only.1

Route, mixing and storage

DailyMed searches found no vial, powder or oil product for turinabol; as an oral tablet it has nothing to mix and no U-100 concentration. The 1991 Schumann study gave single doses by mouth and intravenously to male volunteers; after 10 mg by mouth the compound was almost completely absorbed, and a first-pass effect lowered its systemic availability.2 A 2022 skin-application study by Gessner and colleagues included twelve men; half received oxandrolone only and the other half a mixture of four steroids including DHCMT, as a doping-detection study and not a dosing study.5 Searches for a leaflet found no storage conditions before or after opening.

Half-life and detection

The 1991 Schumann study reports a terminal half-life of 16 h for the unchanged drug after intravenous dosing.2 In the 2021 Loke study, after a single 5 mg dose by mouth in five healthy men, the last sample clearly identified as positive was collected between 9.9 and 44.9 days, and one metabolite, M3, was detectable for 45 days in one volunteer.3 In the Gessner study, all four steroids or their metabolites were detectable in some cases for up to 10-14 days after skin application, with detection windows varying between people and between substances.5

Frequently asked questions

Is turinabol an approved medicine?

A German review says the compound sold as Oral-Turinabol was also approved as a medicine in the GDR.6 The searches found no label or regulator approval record for it.

Is turinabol banned or controlled?

The WADA Prohibited List names dehydrochlormethyltestosterone and puts anabolic agents in class S1, prohibited at all times.7 The US Code lists dehydrochloromethyltestosterone in its definition of anabolic steroid.8

What harms do sources report for turinabol?

The 1984 Vogel series of twenty patients reports roughness of the voice in two patients and slight weight gain in one.1 A case report describes one man with a 5-year history of high-dose Oral-Turinabol use who later presented with an intratesticular leiomyosarcoma.9 Its authors call a cocarcinogenic role a hypothesis from that single case.9

Does a trial registry list turinabol trials?

A ClinicalTrials.gov search for turinabol and dehydrochlormethyltestosterone returned no studies.

References

  1. Folia haematologica (Leipzig, Germany : 1928) (PubMed abstract). [Modification of hypofibrinolytic states by dehydrochlormethyltestosterone]. 1984. pubmed.ncbi.nlm.nih.gov
  2. Die Pharmazie (PubMed abstract). [The pharmacokinetics of Oral-Turinabol in humans]. 1991. pubmed.ncbi.nlm.nih.gov
  3. The Journal of steroid biochemistry and molecular biology (PubMed abstract). Controlled administration of dehydrochloromethyltestosterone in humans: Urinary excretion and long-term detection of metabolites for anti-doping purpose. 2021. pubmed.ncbi.nlm.nih.gov
  4. PubMed. [Drug prevention of thromboembolism in elective hip surgery with reference to thrombophilic conditions]. 1989. pubmed.ncbi.nlm.nih.gov
  5. PubMed. Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application. 2022. pubmed.ncbi.nlm.nih.gov
  6. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz (full text, PubMed Central). Staatsdoping im DDR-Leistungssport: Gesundheitliche Folgen, Aufarbeitung und rechtlicher Ausgleich. 2026. pmc.ncbi.nlm.nih.gov
  7. WADA. WORLD ANTI-DOPING CODE. wada-ama.org
  8. Cornell LII (US Code). 21 U.S. Code § 802 - Definitions. law.cornell.edu
  9. Cancer (PubMed abstract). Intratesticular leiomyosarcoma in a young man after high dose doping with Oral-Turinabol: a case report. 1999. pubmed.ncbi.nlm.nih.gov